LIPG and breast cancer: With regard to the impact of XEN445 on malignancy of breast cancer cells, we found that in concordance with findings from studies of the catalytically inactive LIPG mutant16, XEN445 suppressed TNBC cell proliferation and CSC self-renewal, but not other TNBC properties such as invasiveness, and EMT/basal-like features.